Δευτέρα 8 Μαΐου 2017

White blood cell count predicts response to lung cancer immunotherapy

White blood cell counts can predict whether or not lung cancer patients will benefit from immunotherapy, according to research presented at the European Lung Cancer Conference (ELCC). "Immune checkpoint inhibitors such as nivolumab and pembrolizumab...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qSIvnf
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις